These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8534683)

  • 21. Increased peritoneal solute transport in diabetic peritoneal dialysis patients.
    Lin JJ; Wadhwa NK; Suh H; Cabralda T; Patlak CS
    Adv Perit Dial; 1995; 11():63-6. PubMed ID: 8534740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.
    Akman S; van Westrhenen R; De Waart DR; Hiralall JK; Zweers MM; Krediet RT
    Adv Perit Dial; 2003; 19():24-7. PubMed ID: 14763029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short peritoneal equilibration test: impact of preceding dwell time.
    Twardowski ZJ; Prowant BF; Moore HL; Lou LC; White E; Farris K
    Adv Perit Dial; 2003; 19():53-8. PubMed ID: 14763034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium mass transfer and kinetics in CAPD using calcium-free solutions.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1993; 9():274-9. PubMed ID: 8105942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
    Hung SY; Chung HM
    Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
    Grzegorzewska AE; Mariak I
    Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Continuous ambulatory peritoneal dialysis: is long-term therapy possible?].
    Olszowska A; Antosiewicz S; Pietrzak B
    Pol Merkur Lekarski; 2000 Dec; 9(54):845-8. PubMed ID: 11255652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Continuous ambulatory peritoneal dialysis in patients with diabetes mellitus].
    Ermolenko VM; Melikian AM; Ivashchenko MA; Shutov EV; Zenchenko IV
    Ter Arkh; 2000; 72(6):55-7. PubMed ID: 10900652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased dialysate levels of phospholipids containing unsaturated fatty acid are associated with increased peritoneal transport rate.
    Zhe XW; Gao F; Nie HG; Tian XK; Chen W; Liu HW; Lindholm B; Axelsson J; Wang T
    Am J Nephrol; 2008; 28(6):1007-13. PubMed ID: 18648191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients.
    Passadakis P; Panagoutsos S; Thodis E; Tsivara I; Sopassi F; Kartali S; Vargemezis V
    Adv Perit Dial; 1999; 15():40-4. PubMed ID: 10682070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of the peritoneal platelet activity through the effluent betathromboglobulin levels in CAPD patients.
    Selgas R; Miranda B; Cuesta MV; Garcia-Muñoz S; L-Rivas A; L-Revuel-Ta K; Caparros G; Riñon C; Torre A
    Adv Perit Dial; 1990; 6():26-30. PubMed ID: 1982820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
    Tzamaloukas AH; Oreopoulos DG
    Adv Perit Dial; 1991; 7():81-5. PubMed ID: 1680463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chronic renal insufficiency in the diabetic by dialysis and transplantation].
    Legrain M; Rottembourg J; Jacobs C
    Diabete Metab; 1985 Feb; 11(1):51-69. PubMed ID: 3884405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 36. High peritoneal permeability predisposes to hepatic steatosis in diabetic continuous ambulatory peritoneal dialysis patients receiving intraperitoneal insulin.
    Nevalainen PI; Kallio T; Lahtela JT; Mustonen J; Pasternack AI
    Perit Dial Int; 2000; 20(6):637-42. PubMed ID: 11216552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic parameters of CAPD and CCPD in diabetics with terminal renal insufficiency].
    Thomae U; Kuhlmann H; Herrmann M; Büchele W
    Dtsch Med Wochenschr; 1984 Jun; 109(24):941-4. PubMed ID: 6734446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
    Triolo G; Carta Q; Salomone M; Dani F; Passarino G; Boggio Bertinet D; Segoloni GP; Vercellone A
    Life Support Syst; 1983; 1 Suppl 1():454-6. PubMed ID: 6400733
    [No Abstract]   [Full Text] [Related]  

  • 39. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity.
    Wanless IR; Bargman JM; Oreopoulos DG; Vas SI
    Mod Pathol; 1989 Mar; 2(2):69-74. PubMed ID: 2657721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic patients on CAPD need less aluminum hydroxide as a phosphate binder than non-diabetics.
    Macia M; Coronel F; Torrente J; Sanchez A; Tornero F; Barrientos A
    Adv Perit Dial; 1990; 6():50-2. PubMed ID: 1982839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.